205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.78%
Negative net income growth while AVGO stands at 137.72%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
1.32%
Less D&A growth vs. AVGO's 59.14%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
121.43%
Some yoy growth while AVGO is negative at -103.48%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
41.67%
SBC growth while AVGO is negative at -1.46%. John Neff would see competitor possibly controlling share issuance more tightly.
-274.09%
Both reduce yoy usage, with AVGO at -836.84%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-140.96%
AR is negative yoy while AVGO is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-394.44%
Negative yoy inventory while AVGO is 170.65%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-232.20%
Both negative yoy AP, with AVGO at -245.74%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-996.77%
Both reduce yoy usage, with AVGO at -1195.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
80.84%
Some yoy increase while AVGO is negative at -61.84%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-42.68%
Negative yoy CFO while AVGO is 0.07%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-15.45%
Both yoy lines negative, with AVGO at -68.39%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Both yoy lines negative, with AVGO at -95.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
43.17%
Purchases growth of 43.17% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
46.41%
We have some liquidation growth while AVGO is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
126.27%
We have some outflow growth while AVGO is negative at -200.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
138.98%
We have mild expansions while AVGO is negative at -1326.92%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
75.00%
Debt repayment at 75-90% of AVGO's 94.00%. Bill Ackman urges more debt clearance to match competitor’s lower leverage.
1441.67%
We slightly raise equity while AVGO is negative at -21.79%. John Neff sees competitor possibly preserving share count or buying back shares.
-15.79%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.